Sitagliptin Hydrochloride is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an antidiabetic agent to manage type 2 diabetes by enhancing the body's natural insulin secretion and suppressing glucagon… Read more
Sitagliptin Hydrochloride is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an antidiabetic agent to manage type 2 diabetes by enhancing the body's natural insulin secretion and suppressing glucagon release. This category features high-quality analytical standards, including the active pharmaceutical ingredient, its related impurities, and stable isotope labelled compounds like Sitagliptin D4 Hydrochloride and rac-Sitagliptin-d4 Hydrochloride. These reference standards are critical for pharmaceutical laboratories performing rigorous quality control and method validation. By utilizing these materials, analysts can ensure precise identification and quantification of the drug substance and its degradation products. Furthermore, the inclusion of isotopically labelled internal standards facilitates accurate impurity profiling and quantitation during bioanalytical method development, supporting the comprehensive stability and safety testing required for regulatory compliance throughout the drug development lifecycle.